myopathy, lactic acidosis, and sideroblastic anemia 2

The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.

Disease Overview

Any mitochondrial myopathy and sideroblastic anemia in which the cause of the disease is a mutation in the YARS2 gene.

Synonyms

MLASA2
YARS2 mitochondrial myopathy and sideroblastic anaemia
YARS2 mitochondrial myopathy and sideroblastic anemia
mitochondrial myopathy and sideroblastic anaemia caused by mutation in YARS2
mitochondrial myopathy and sideroblastic anemia caused by mutation in YARS2
myopathy, lactic acidosis, and sideroblastic Anaemia type 2
myopathy, lactic acidosis, and sideroblastic Anemia type 2
myopathy, lactic acidosis, and sideroblastic anemia 2

GARD Disease Summary

The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

View report

OMIM

Online Mendelian Inheritance In Man (OMIM) has a summary of published research about this condition and includes references from the medical literature. The summary contains medical and scientific terms, so we encourage you to share and discuss this information with your doctor. OMIM is authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine.